Overview

Observational Study to Investigate the Occurrence of Bleeding in Postmenopausal Women Treated With Estradiol/NETA for 12 Months

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
0
Participant gender:
Female
Summary
This study is conducted in Europe. The primary aim of this observational study is to investigate the occurrence of bleeding in women taking 0.5 mg estradiol and 0.1 mg norethisterone acetate (NETA) for 12 months.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Norethindrone
Norethindrone Acetate
Polyestradiol phosphate
Criteria
Inclusion Criteria:

- Informed consent, permitting the data to be processed within the scope of the study,
is obtained from the patient before any study-related activities

- Postmenopausal amenorrhoeic women

- Treatment with previously combined HRT discontinued at least 3 months prior to start
of 0.5 mg estradiol and 0.1 mg norethisterone acetate treatment